Journal: BMC Cancer
Article Title: Dnmt3a is downregulated by Stat5a and mediates G0/G1 arrest by suppressing the miR-17-5p/Cdkn1a axis in Jak2 V617F cells
doi: 10.1186/s12885-021-08915-0
Figure Lengend Snippet: Aberrant activation of the JAK-STAT pathway represses Dnmt3a transcription and translation via Stat5a. A. The expression level of Jak2, p-Jak2, Stat5a, p-Stat5a and Dnmt3a in wild-type and Jak2 V617F BaF3 cells. Full-length blot images are presented in Supplementary Fig. . B. Transcription level of DNMT3a in bone marrow mononuclear cells from JAK2 V617F MPN patients and normal controls. C. p-Stat5a and Dnmt3a of Jak2 V617F Baf3 cells incubated with AZ960. Full-length blot images are presented in Supplementary Fig. . D. p-Stat5a and Dnmt3a of Jak2 V617F Baf3 cells incubated with LY2784544. Full-length blot images are presented in Supplementary Fig. . E. In Jak2 V617F BaF3 cells, the protein expression level of Dnmt3a after Stat5a was knocked down. Full-length blot images are presented in Supplementary Fig. . F. The transcriptional level of Dnmt3a in Jak2 V617F Baf3 cells with or without LY2784544 incubation
Article Snippet: Primary antibodies against Jak2 (cat. no. 3230), p-Jak2 (cat. no. 3771), Stat5a (cat. no. 94205), p-Stat5a (cat. no. 4322), Dnmt3a (cat. no. 3598), β-actin (cat. no. 8457) and Cdkn1a (cat. no. 64016) were purchased from Cell Signaling Technology (USA).
Techniques: Activation Assay, Expressing, Incubation